R1 RCM to Present at the 41st Annual J.P. Morgan Health Care Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
R1 RCM, a prominent provider of technology-driven healthcare solutions, will present at the 41st Annual J.P. Morgan Health Care Conference on January 10, 2023, at 7:30 am PT. The event will highlight R1's advancements in enhancing patient experience and financial performance for healthcare providers. Investors can access a live audio webcast on R1's website, with a replay available for 30 days afterward. The company focuses on delivering scalable solutions that optimize revenue and reduce operating costs.
Details
News Market Reaction – RCM
The recorded move for RCM in the trading session of this news was -1.45%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MURRAY, Utah, Dec. 22, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 41st Annual J.P. Morgan Health Care Conference on Tuesday, January 10, 2023, at 7:30 am PT.
A live audio webcast of the presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webcast will be available for 30 days following the live webcast.
About R1 RCM
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.
Contact:
R1 RCM Inc.
Investor Relations:
Atif Rahim
312.324.5476
investorrelations@r1rcm.com
Media Relations:
Natalie Pacini
415.335.7641 Ext. 43
natalie@highwirepr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.